– CNBC
RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $288
RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and raises the price target from $281 to $288.